Early manifestation of macrovasculopathy in newly diagnosed never treated type II diabetic patients with no traditional CVD risk factors

Diabetes Research and Clinical Practice

Volumn 80, Issue 2, 2008, Pages 253-258

  Rahman, Sayeeda ^a   Ismail, Aziz Al Safi ^a   Ismail, Shaiful Bahari ^a   Naing, Nyi Nyi ^a   Rahman, Abdul Rashid Abdul ^b  

^a SCHOOL OF MEDICAL SCIENCES   (Malaysia)

^b CYBERJAYA UNIVERSITY COLLEGE OF MEDICAL SCIENCES   (Malaysia)

Author keywords

Arterial stiffness; Augmentation index; Macrovascular diseases; Pulse wave velocity

Indexed keywords

ADULT; AGED; ARTERIAL STIFFNESS; ARTICLE; AUGMENTATION INDEX; CARDIOVASCULAR DISEASE; CLINICAL FEATURE; CONTROLLED STUDY; DIABETIC ANGIOPATHY; GLUCOSE BLOOD LEVEL; HEMODYNAMIC PARAMETERS; HUMAN; IMPAIRED GLUCOSE TOLERANCE; MAJOR CLINICAL STUDY; NON INSULIN DEPENDENT DIABETES MELLITUS; PULSE WAVE; RISK FACTOR; VASCULAR DISEASE;

ADULT; AGED; BLOOD PRESSURE; DIABETES MELLITUS, TYPE 2; DIABETIC ANGIOPATHIES; FEMALE; GLUCOSE INTOLERANCE; GLUCOSE TOLERANCE TEST; HEART RATE; HUMANS; LIPIDS; MALAYSIA; MALE; MASS SCREENING; MIDDLE AGED; QUESTIONNAIRES; RISK FACTORS; VASCULAR DISEASES;

EID: 41749106683     PISSN: 01688227     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.diabres.2007.12.010     Document Type: Article

References (44)

1. Stamler J., Vaccaro O., Neaton J.D., and Wentworth D. Diabetes, other risk factors, and 12-yr cardiovascular mortality for men screened in the Multiple Risk Factor Intervention Trial. Diabetes Care 16 (1993) 434-444
2. Yu Y., and Lyons T.J. A lethal tetrad in diabetes: hyperglycemia, dyslipidemia, oxidative stress, and endothelial dysfunction. Am. J. Med Sci. 330 (2005) 227-232
3. Stratton I.M., Adler A.I., Neil H.A.W., Matthews D.R., Manley S.E., Cull C.A., et al. Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study. BMJ 321 (2000) 405-412
4. Tominaga M., Eguchi H., Manaka H., Igarashi K., Kato T., and Sekikawa A. Impaired glucose tolerance is a risk factor for cardiovascular disease, but not impaired fasting glucose. The Funagata Diabetes Study. Diabetes Care 22 (1999) 920-924
5. Schram M.T., Henry R.M.A., van Dijk R.A.J.M., Kostense P.J., Dekker J.M., Nijpels G., et al. Increased central artery stiffness in impaired glucose metabolism and type 2 diabetes. The Hoorn study. Hypertension 43 (2004) 176-181
6. Karasik A. Glycaemic control is essential for effective cardiovascular risk reduction across the type 2 diabetes continuum. Ann Med. 37 (2005) 250-258
7. O'Rourke M.F., and Mancia G. Arterial stiffness. J. Hypertension 17 (1999) 1-4
8. Duprez D.A., De Buyzere M.M., De Bruyne L., Clement D.L., and Cohn J.N. Small and large artery elasticity indices in peripheral arterial occlusive disease (PAOD). Vasc. Med. 6 (2001) 211-214
9. Woodman R.J., and Watts G.F. Measurement and application of arterial stiffness in clinical research: focus on new methodologies and diabetes mellitus. Med. Sci. Monit. 9 (2003) RA101-RA110
10. Henry R.M.A., Kostense P.J., Spijkerman A.M.W., Dekker J.M., Nijpels G., Heine R.J., et al. Arterial stiffness increases with deteriorating glucose tolerance status. The Hoorn study. Circulation 107 (2003) 2089-2095
11. Nigm C.A., Rahman A.R.A., and Ibrahim A. Pulse wave velocity as an index of arterial stiffness: a comparison between newly diagnosed (untreated) hypertensive and normotensive middle-aged Malay men and its relationship with fasting insulin. Acta Cardiol. 54 (1999) 277-282
12. Wilkinson I.B., Fuchs S.A., Jansen I.M., Spratt J.C., Murray G.D., Cockcroft J.R., et al. Reproducibility of pulse wave velocity and augmentation index measured by pulse wave analysis. J. Hypertension 16 (1998) 2079-2084
13. WHO. WHO Consultation Report: Definition and Diagnosis and Classification of Diabetic Mellitus and its Complications (1999), World Health Organization, Geneva
14. Lacy P.S., O'Brien D.G., Stanley A.G., Dewar M.M., Swales P.P., and Williams B. Increased pulse wave velocity is not associated with elevated augmentation index in patients with diabetes. J. Hypertension 22 (2004) 1937-1944
15. Cruickshank K., Lisa R., Anderson S.G., Wright J.S., Dunn G., and Gosling R.G. Aortic pulse wave velocity and its relationship to mortality in diabetes and glucose tolerance. An integrated index of vascular function. Circulation 106 (2002) 2085-2090
16. Amar J., Chamontin B., Pelissier M., Garelli I., and Salvador M. Influence of glucose metabolism on nycthemeral blood pressure variability in hypertensive with an elevated waist-hip ratio: a link with arterial distensibility. Am. J. Hypertension 8 (1995) 426-428
17. Emoto M., Nishizawa Y., Kawagishi T., Maekawa K., Kogawa K., Hiura Y., et al. Stiffness indexes of the common carotid and femoral arteries are associated with insulin resistance in NIDDM. Diabetes Care 21 (1998) 1178-1182
18. Lo C.S., Relf I.R., Myers K.A., and Wahlqvist M.L. Doppler ultrasound recognition of preclinical changes in arterial wall in diabetic subjects: compliance and pulse-wave damping. Diabetes Care 9 (1986) 27-31
19. Wahlqvist M.L., Lo C.S., Myers K.A., Simpson R.W., and Simpson J.M. Putative determinants of arterial wall compliance in NIDDM. Diabetes Care 11 (1988) 787-790
20. Megnien J.L., Simon A., Valensi P., Flaud P., Merli I., and Levenson J. Comparative effects of diabetes mellitus and hypertension on physical properties of human large arteries. J. Am. Coll. Cardiol. 20 (1992) 1562-1568
21. Lehmann E.D., Gosling R.G., and Sonksen P.H. Arterial wall compliance in diabetes. Diabet. Med. 9 (1992) 114-119
22. Tanokuchi S., Okada S., and Ota Z. Factors related to aortic pulse-wave velocity in patients with non-insulin-dependent diabetes mellitus. J. IntMed. Res. 23 (1995) 423-430
23. Taniwaki H., Shoji T., Emoto M., Kawagishi T., Ishimura E., Inaba M., et al. Femoral artery wall thickness and stiffness in evaluation of peripheral vascular disease in type 2 diabetes. Atherosclerosis 158 (2001) 207-214
24. Salomaa V., Riley W., Kark J.D., Nardo C., and Folsom A.R. Non-insulin-dependent diabetes mellitus and fasting glucose and insulin concentrations are associated with arterial stiffness indexes: The ARIC Study. Circulation 91 (1995) 1432-1443
25. van Dijk A.J.M., Dekker J.M., Nijpels G., Heine R.J., Bouter L.M., and Stehouwer C.D.A. Brachial artery pulse pressure and common carotid artery diameter: mutually independent associations with mortality in subjects with a recent history of impaired glucose tolerance. Eur. J. Clin. Invest. 31 (2001) 756-763
26. Ohnishi H., Saitoh S., Takagi S., Ohata J., Isobe T., Kikuchi Y., et al. Pulse wave velocity as an indicator of atherosclerosis in impaired fasting glucose. The Tanno and Sobetsu Study. Diabetes Care 26 (2003) 437-440
27. Aoun S., Blacher J., Safar M.E., and Mourad J.J. Diabetes mellitus and renal failure: effects on large artery stiffness. J. Hum. Hypertens. 15 (2001) 693-700
28. Brooks B.A., Molyneaux L.M., and Yue D.K. Augmentation of central arterial pressure in Type 2 diabetes. Diabet. Med. 18 (2001) 374-380
29. Cameron J.D., Pinto E.S., Bulpitt C.J., and Rajkumar C. The aging of elastic and muscular arteries. A complication of diabetic and non-diabetic subjects. Diabetes Care 26 (2003) 2133-2138
30. McVeigh G., Brennan G., Hayes R., Cohn J., Finkelstein S., and Johnston D. Vascular abnormalities in non-insulin-dependent diabetes mellitus identified by arterial waveform analysis. Am. J. Med. 95 (1993) 424-430
31. Jennings G.L.R., and Kingwell B.A. Measuring arterial function in diabetes. J. Hypertension 22 (2004) 1863-1865
32. Hope S.A., Tay D.B., Meredith I.T., and Cameron J.D. Use of arterial transfer functions for the derivation of central aortic waveform characteristics in subjects with Type 2 diabetes and cardiovascular disease. Diabetes Care 27 (2004) 746-751
33. Haffner S.M., Stern M.P., Hazuda H.P., Mitchell B.D., and Patterson J.K. Cardiovascular risk factors in confirmed prediabetic individuals: does the clock for coronary heart disease start ticking before the onset of clinical diabetes?. JAMA 263 (1990) 2893-2898
34. Goyder E., and Irwig L. Screening for diabetes: what are we really doing?. BMJ 317 (1998) 1644-1646
35. Mafauzy M., Mokhtar N., Wan Mohamad W.B., and Musalmah M. Diabetes mellitus and associated cardiovascular risk factors in north-east Malaysia. Asia Pac. J. Public Health 11 (1999) 16-19
36. Mafauzy M., Mokhtar N., and Wan Mohamad W.B. Hypertension and associated cardiovascular risk factors in Kelantan. Med. J. Malaysia 58 (2003) 556-564
37. Mohamad W.B., Mokhtar N., Mafauzy M., Mustaffa B.E., and Musalmah M. Prevalence of obesity and overweight in northeastern peninsular Malaysia and their relationship with cardiovascular risk factors. Southeast Asian J. Trop. Med. Public Health 27 (1996) 339-342
38. Ismail I.S., Nazaimoon W.M., Mohamad W.B., Letchuman R., Singaraveloo M., Pendek R., et al. Sociodemographic determinants of glycaemic control in young diabetic patients in peninsular Malaysia. Diabetes Res. Clin. Pract. 47 (2000) 57-69
39. Tedesco M.A., Natale F., DiSalvo G., Caputo S., Capasso M., and Calabró R. Effects of coexisting hypertension and type 2 diabetes mellitus on arterial stiffness. J. Human Hypertens. 18 (2004) 469-473
40. Lim H.S., and Lip G.Y.H. Arterial stiffness in diabetes and hypertension. J. Hum. Hypertens. 18 (2004) 467-468
41. Barroso I. Genetics of Type 2 diabetes. Diabet. Med. 22 (2005) 517-535
42. Ramachandran A., Snehalatha C., Viswanathan V., Viswanathan M., and Haffner S.M. Risk of noninsulin dependent diabetes mellitus conferred by obesity and central adiposity in different ethnic groups: a comparative analysis between Asian Indians, Mexican Americans and Whites. Diabetes Res. Clin. Pract. 36 (1997) 121-125
43. Neutel J.M., Smith D.H.G., Graettinger W.F., and Weber M.A. Dependency of arterial compliance on circulating neuroendocrine and metabolic factors in normal subjects. Am. J. Cardiol. 69 (1992) 1340-1344
44. Nathan D.M., Meigs J., and Singer D.E. The epidemiology of cardiovascular disease in type 2 diabetes mellitus: how sweet it is ... or is it?. Lancet 350 (1997) s4-s9